Morning Newb , with 4 x Phase II Trials to be delivered by mid 2025 there will be constant updates surrounding Trial Design/ Registration and Trial Patient Recruitment , first patient dosed etc ..
4 min 50 sec in to presentation , constant updates for the next 6 months
December 2024 , Booked in for delivery of Trial Results in the USA .....
Skin scaring is also highly visual and the results are easily understood SNT 6302 has already shown tremendous positive results , some previous Trial Patients are still utilising the treatment.
This is the type of visual results that will be presented to market ,,, The Science is simple and effective , Investors don't need a PHD to understand the Science.
Those that know my investment strategy is I hunt Catalysts and this Biotech is loaded to the gunnels ... exciting times ahead ...NZT
(20min delay)